Skip to main content
Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd — Investor Relations & Filings

Ticker · TLSA ISIN · BMG889121031 LEI · 984500769407C5E46F42 US Professional, scientific and technical activities
Open in API
Filings indexed 460 across all filing types
Latest filing 2020-08-20 Regulatory Filings
Country BM Bermuda
Listing US TLSA

About Tiziana Life Sciences Ltd

https://www.tizianalifesciences.com/

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company focused on developing innovative immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's core strategy involves utilizing alternative drug delivery routes, such as intranasal administration, to modulate the immune system. Its lead clinical candidate, foralumab (TZLS-401), is the only fully human anti-CD3 monoclonal antibody being investigated for neurological conditions. Foralumab is in clinical development for the treatment of Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS), Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), and Multiple System Atrophy (MSA). The company's pipeline also includes an anti-IL-6 receptor monoclonal antibody (TZLS-501) for potential application in lung diseases.

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 100% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains a regulatory news service announcement about retaining a scientific advisory board member. The document is short (2867 characters) and primarily serves to furnish an announcement rather than provide detailed financial data or a full report. It explicitly states that the attached announcement is not "filed" for certain regulatory purposes and is an RNS announcement. There is no substantive financial data or detailed report content. According to the rules, such a document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other categories and for announcements like this.
2020-08-20 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains a regulatory news service announcement about a patent grant, but the main content is an announcement rather than a full report. The document length is only 2969 characters, which is short and primarily serves to furnish an announcement rather than provide detailed financial data or a comprehensive report. According to the MENU VS MEAL RULE, this is an announcement of information rather than the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-08-18 English
ACQUISITION OF BENEFICIAL OWNERSHIP
Major Shareholding Notification
2020-08-12 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 100% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references a Regulatory News Service (RNS) announcement about a presentation at a biotechnology conference. The document is short (2924 characters) and primarily serves to furnish the RNS announcement as an exhibit. It does not contain detailed financial data, management discussion, or full report content. According to the rules, such a document is a regulatory filing that provides an announcement or supplementary information rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-08-11 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 100% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references an attached Regulatory News Service (RNS) announcement about a notification of major holdings in the company. The document itself is short (2915 characters) and primarily serves to furnish the RNS announcement rather than containing substantive financial data or detailed report content. It does not contain financial statements or detailed analysis but rather an announcement of a regulatory filing. According to the rules, such documents are classified as Regulatory Filings (RNS) because they do not fit into more specific categories and are not full reports themselves.
2020-08-10 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references an attached Regulatory News Service Announcement about the closing of a $57.25 million offering. The document itself is short (2534 characters) and primarily serves to furnish this announcement rather than provide detailed financial data or a full report. It does not contain comprehensive financial statements or management discussion. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2020-08-05 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.